Immunovant Inc (NASDAQ:IMVT)

Delayed Data
As of 3:59pm ET
 -0.35 / -1.67%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Immunovant Inc have a median target of 28.00, with a high estimate of 32.00 and a low estimate of 4.00. The median estimate represents a +35.53% increase from the last price of 20.66.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Immunovant Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.32%
Growthannually -6.41%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.